Moxalactam treatment of anaerobic infections in cancer patients.
Of 30 patients with predominantly anaerobic localized infections superimposed on chronic tissue damage related to trauma, ischemia, or tumor, 22 (73%) responded satisfactorily to moxalactam therapy. Moxalactam-resistant anaerobic pathogens emerged in two patients and were responsible for treatment f...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1982
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC183800/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6217784/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.22.4.604 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|